Default company panoramic image


Hygieia is commercializing a clinically-proven approach to managing diabetes, delivered as an easy-to-use handheld medical device.

  • Stage Full Product Ready
  • Industry Medical Devices and Equipment
  • Location Ann Arbor, MI, USA
  • Currency USD
  • Founded July 2008
  • Employees 10
  • Website

Company Summary

Hygieia is commercializing a new diabetes management service based on University of Michigan technology. The service addresses the escalating needs of the global diabetes epidemic by improving clinical efficacy while driving down per-patient costs.

Customers - UK-based health systems, doctors and patients - receive d-Nav™, Hygieia's simple handheld device, and proprietary consumables, through a subscription-based disease management service.


  • Default avatar
    Karen Drexler

    Ms. Drexler Founded Amira Medical Inc, and served as its President and CEO until the company was sold to Roche. Ms. Drexler was President of Aperon Biosystems, and had significant strategic and operational responsibilities at LifeScan, where she played key roles in the development and launch of the One Touch system and in the sale of LifeScan to J&J. Ms. Drexler sits on the board of diaDexus, a publicly-traded In-Vitro Diagnostic company.

  • Default avatar
    Eran Bashan

    Mr. Bashan brings Hygieia almost twenty years of experience in leadership, execution, research, innovation, and team building. He demonstrated his ability to attract top candidates to Hygieia from a variety of disciplines to create a cohesive team. Mr. Bashan has experience in engineering management overseeing development of consumer electronic products in startups and a $2B/yr company.

  • Default avatar
    Robert Parnell
    VP Business Development

    Before joining Hygieia, Mr. Parnell was VP Global Licensing & New Business Development at Bayer HealthCare’s Diabetes Care Division, following ten years in the same role at Bayer’s Diagnostics Division, one of the world’s leading diagnostics companies, acquired by Siemens Medical Solutions for $6.5 Billion. Earlier in his career, Mr. Parnell held leadership positions with Kodak Diagnostics (now J&J) and Amersham International (GE Healthcare).

  • Default avatar
    Elizabeth North
    VP Sales and Marketing

    Ms. North is a seasoned sales and marketing professional with 30 years of practical experience in the IVD/Self Blood Glucose Monitoring market both domestically and globally initially with Bayer Corp. After leaving Bayer Diabetes Care in 2006, Ms. North spent two years working for Home Diagnostics Inc. as a Marketing Director.

  • Default avatar
    David Bloom
    VP Products

    Mr. Bloom is a veteran product development executive, with 25 years of experience bringing new technologies to market for IBM, Unisys, StorageTek, and successful entrepreneurial ventures. Most recently, Mr. Bloom was CIO of Optimization Group, where he received the Innovation Michigan award for his work with Genentech. Mr. Bloom has led enterprise and embedded systems development in life science, handheld technology, biometrics, and sensors.


  • Default avatar
    Timothy Damschroder, Bodman
    Default avatar
    Jeff Dolowy, Plante-Moran

Previous Investors

  • Default avatar
    Oakwood Medical Investors
    Default avatar
    Michigan Life Ventures